We thus concluded that tumor cells, especially in the G2 stage, are sensitized for IGF1, IGF2 and Insulin stimulation by increased glucose in the TME, as these growth hormones can activate IGF1R (54). The gene discussed is IGF1R; the disease is neoplasm.